Northwest Biotherapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NBYB for the last quarter is 263.21 k EUR, and it's 34.72% lower compared to the previous quarter. The net income of Q1 24 is -16.97 M EUR.